Timothy An-thy Chan
Memorial Sloan Kettering Cancer Center
2 papers in the Anchorcite directory, published between 2014 and 2015, cited 12,267 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Cancer Genomics and Diagnostics · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
- Immunotherapy and Immune Responses · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
Frequent co-authors
- Alexandra Snyder · 2 papers
- Vladimir Makarov · 2 papers
- Jianda D. Yuan · 2 papers
- Phillip Wong · 2 papers
- Teresa S. Ho · 2 papers
- Cameron Bruggeman · 2 papers
- Taha Merghoub · 2 papers
- Jedd D. Wolchok · 2 papers
Papers
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience · 2015 · 7,918 citations
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this therapy, we used whole-exome sequencing of non-small cell lung cancers treated with pembrolizumab, an…
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine · 2014 · 4,349 citations
BACKGROUND: Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T…
Metadata from OpenAlex (CC0).